
025 - The Parenteral Drug Association & Evolution of Drug Development with Michael Carroll
Mar 12, 2021 - 00:31:51
Radio and PodcastLive Radio & Podcasts
What We Covered 00:59 – Hedley Rees joins the show to share his background in the pharmaceutical industry, his thoughts on Big Pharma and issues he’s observed with medicine coming to market 09:43 – Hedley speaks to the i...
012 - Taking Medicines Back to The Future – A Discussion with Hedley Rees on Value Chain vs. Supply Chain: What's the Difference? is an episode from CMC Live - Chemistry, Manufacturing & Controls by DSI. What We Covered 00:59 – Hedley Rees...
This episode belongs to CMC Live - Chemistry, Manufacturing & Controls.
Use the player on this page to stream the episode online.
Published Oct 16, 2020, 00:44:38 long, audio available.
What We Covered 00:59 – Hedley Rees joins the show to share his background in the pharmaceutical industry, his thoughts on Big Pharma and issues he’s observed with medicine coming to market 09:43 – Hedley speaks to the importance of designing supply chains strategically and why your supply chain is actually your value chain 17:51 – Hedley discusses outsourcing in the pharmaceutical industry 24:07 – Hedley provides his thoughts on Quality by Design (QBD), including changes that must be made to the process 39:22 – Hedley shares some of his upcoming projects 42:27 – Ed, Brian and Meranda thank Hedley for joining the show Tweetable Quotes “If they all beat together at the same time, instead of taking sixteen years for penicillin to come to market it would take maybe four years.” “The main point between strategic supply team management is you actually engage with the end user of your product the same way as Apple would or any company who really builds value into their products.” “The value that you add – the money you bring in – has got to be less than the cost that you incur in the business and then you obviously make a profit grow.” “In terms of procurement, the industry has outsourced this critical asset.” “The problem with pharma is that there is no competition because once you’ve got a patented molecule approved, the most that’s gonna happen is you get an oligopoly where two or three companies make blockbuster revenue.” “The body is the most complex, connected thing in the world.” “The other thing that people have noticed is that you can develop a drug now without being a pharma company.” Relevant Links Design Space InPharmatics - LinkedIn Design Space InPharmatics - Twitter Edward Narke on LinkedIn Hedley Rees on LinkedIn Hedley’s Book – Taming the Big Pharma Monster By Speaking Truth to Power Hedley’s Blog PharmaFlow Cutting Through the QBD Foliage, Aiming for the Roots Article
You can listen to 012 - Taking Medicines Back to The Future – A Discussion with Hedley Rees on Value Chain vs. Supply Chain: What's the Difference? online on Radio and Podcast. Open the player on this page to stream the available audio.
012 - Taking Medicines Back to The Future – A Discussion with Hedley Rees on Value Chain vs. Supply Chain: What's the Difference? is an episode from CMC Live - Chemistry, Manufacturing & Controls by DSI.
This episode is 00:44:38 long.
This episode was published on Oct 16, 2020.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from CMC Live - Chemistry, Manufacturing & Controls when more episodes are available from the podcast feed.
You can listen to 012 - Taking Medicines Back to The Future – A Discussion with Hedley Rees on Value Chain vs. Supply Chain: What's the Difference? on this page when the episode audio is available from the podcast feed.
012 - Taking Medicines Back to The Future – A Discussion with Hedley Rees on Value Chain vs. Supply Chain: What's the Difference? is from CMC Live - Chemistry, Manufacturing & Controls by DSI.
Published Oct 16, 2020 and 00:44:38 long